MAL2 and cancer: Overexpression of MAL2 has also been reported in other cancers, including primary ovarian carcinoma [23,24] and ascites [25], and pancreatic carcinoma [26], where MAL2 has since been employed as a discriminator of pancreatic carcinoma versus chronic pancreatitis [27].